Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2020

Nov 9, 2020

30145_dirs_2020-11-09_2ccebc64-cf30-4018-94f7-fced03e7716d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2020-11-05

Reporting Person: Kane Brian A (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-05 Humana Common M 29995 $217.415 Acquired 67023 Direct
2020-11-05 Humana Common F 218 $459.855 Disposed 66805 Direct
2020-11-05 Humana Common S 29536 $446.8749 Disposed 37269 Direct
2020-11-05 Humana Common S 19617 $442.7445 Disposed 17652 Direct
2020-11-05 Humana Common G 120 Disposed 17532 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-05 Options $217.415 M 29995 Disposed 2024-03-08 Humana Common (29995) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options $268.47 2025-02-19 Humana Common (12041) 12041 Direct
Options $307.965 2026-02-25 Humana Common (11674) 11674 Direct
Options $350.7875 2027-02-24 Humana Common (12535) 12535 Direct
Restricted Stock Units $ Humana Common (932) 932 Direct
Restricted Stock Units $ Humana Common (1759) 1759 Direct
Restricted Stock Units $ Humana Common (2494) 2494 Direct

Footnotes

F1: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 19,997 options vesting in three annual increments, and 9,998 options fully vest three years from the date of grant.

F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/18, vesting in three increments from 02/19/19 to 02/19/21.

F3: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/19, vesting in three increments from 02/25/20 to 02/25/22.

F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

F5: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7: Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20.

F8: Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21.

F9: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F10: Shares swapped for the payment of purchase price on stock option exercise using fair market value on November 4, 2020 pursuant to Humana Inc.'s 2011 Stock Incentive Plan.

F11: Shares sold at prices ranging from $442.84 to $450.87. Price reported is weighted average sales price.

F12: Shares sold at prices ranging from $439.58 to $450.90. Price reported is weighted average sales price.

F13: Shares represent gift/charitable donation effective November 5, 2020, in which no value was received in return.